NEWS / NEWS CENTER
Companies adhering to the "quality of survival, reputation and development" business philosophy
The function of product protection and value-added is a silent salesman and an indispensable link in product sales.
On the basis of 2013, the 2014 China Medical Packaging Innovation and Management Conference will return strongly. In addition to the usual high-quality guest line-up, we will also contribute more valuable topics and interactive forms. The Summit will invite authoritative experts from relevant government accreditation and testing institutions and relevant leaders from Pfizer, Sanofi, Johnson & Johnson, Baxter, Takazu and Bristol-Myers Squibb to attend the scene, from the revised registration standards of pharmaceutical packaging materials, safe and compatible medical packaging materials, scientific and humanized pharmaceutical packaging design, exquisite and exquisite. Leading packaging technology and other content to conduct in-depth discussion and case sharing, to provide a platform for delegates to learn and dialogue, but also for like-minded colleagues in the industry to build a valuable interpersonal network.
Reasons for participation
The exhibition links up with more than one action: not only can we participate in the largest and highest-grade pharmaceutical exhibitions in Asia-Pacific region, see the latest medical packaging materials, but also learn the thinking and practice of the world's leading pharmaceutical enterprises in the field of pharmaceutical packaging!
Authoritative Speaker: The Summit invites authoritative experts from relevant government accreditation and testing institutions and the relevant persons in charge of pharmaceutical packaging from Pfizer, Sanofi, Johnson & Johnson, Baxter, Takazu, Bristol-Myers Squibb and other compulsory pharmaceutical enterprises in the world to come to the scene personally.
Professional Dialogue Platform: The summit will attract more than 120 leaders from the government, leading pharmaceutical companies and pharmaceutical packaging companies. To provide a platform for learning and dialogue for all participants, and to build a valuable interpersonal network for like-minded colleagues in the industry.
Highlights of the conference
Cooperation - Collaboration and Exchange with Top Industry Suppliers
Understanding-Helping Pharmaceutical Enterprises to Deeply Understand the Latest Development of Pharmaceutical Packaging in China
Insight - Deep Analysis of Fresh Ideas and Encouraging Environment
Interaction - Interaction with professionals who are enthusiastic about the future development of pharmaceutical packaging
Listening - Listening to Industry Leaders Sharing Industry Frontier New Technologies and Practical Application
Lecture 1: Revised Registration Standards for Pharmaceutical Packages
In order to strengthen the supervision and management of packaging materials and containers in direct contact with drugs and ensure the quality of packaging materials, on July 20, 2004, the State Food and Drug Administration promulgated the Measures for the Management of Packaging Materials and Containers in Direct Contact with Drugs (Decree No. 13 of the Administration), which unified the supervision and control of packaging materials and containers in direct contact with drugs.
Director/China Institute of Food and Drug Verification Institute of Packaging Materials and Pharmaceutical Accessories
Director/Pharmaceutical Packaging Material Room of Zhejiang Institute of Food and Drug Inspection
Deputy Director/Shanghai Food and Drug Packaging Material Testing Institute
Lecture 2: Discussions on the Compliance of Regulations and Regulations on Pharmaceutical Packages
In addition to providing protective properties, the safety and consistency of pharmaceutical packages are also very important considerations. The laws and regulations on pharmaceutical packaging issued by the state have become an important yardstick for enterprises to develop pharmaceutical packaging. However, there is a dilemma in the development and management of pharmaceutical packaging materials in China. In view of stricter and stricter regulations and increasingly difficult to match the upstream raw materials, pharmaceutical companies have lamented the enormous pressure. In this lecture, the speaker will focus on Johnson & Johnson's response to this issue, and share relevant cases.
Senior Manager of Global Engineering/Johnson & Johnson (China) Co., Ltd.
Chapter 3: Discussing the new development trend of pharmaceutical packaging materials from the angle of design, technology and material
With the development of economy and technology, pharmaceutical packaging materials for special commodities are constantly updated. With the enhancement of people's awareness of environmental protection, pharmaceutical packaging is moving towards a safer, more convenient and pollution-free direction. The application of new materials, new technologies and new processes in the field of pharmaceutical packaging has become a new trend in the future development of pharmaceutical packaging materials.
Chapter Four: Packaging Design and Cost Saving
With the deepening of marketization and the intensification of competition, pharmaceutical companies are facing more and more price pressures, such as raw materials, labor, logistics, competition, government pricing and so on. In order to meet the different requirements of medicines, various new packaging materials are more and more widely used in the field of pharmaceutical packaging, and to a certain extent, it also pushes up the cost of packaging materials. How to develop and design packaging by using new technology, new materials, new technology and new ideas, and how to reduce the cost on the premise of ensuring product quality, has become a focus of many enterprises and packaging developers.
China Packaging Development Manager/Sanofi (China)
Lecture 5: Safety and Compatibility of Pharmaceutical Packages and Drugs
Pharmaceutical finished products and packaging systems used together should meet their expected applications, and the safety of pharmaceutical packaging materials to be registered or sold must be effectively assessed. Safety assessment of pharmaceutical packaging includes chemical assessment (assessment of extractable and extractable substances), biological assessment, and toxicological assessment. At the same time, drug compatibility evaluation, including drug stability, and drug adsorption properties of the package, should also be studied. The methods, concepts, biological and toxicological assessment processes and the latest research progress of chemical assessment of drug package safety were introduced.
Technical Manager/Suzhou Baite Medical Supplies Co., Ltd.
Chapter 6: Development Trend of Pharmaceutical Packages in the Future
With the emergence of new drugs and the escalation of strict laws and regulations on pharmaceutical packaging materials, the safety and diversification of materials and forms of pharmaceutical packaging materials have become the focus of attention of enterprises. Experts predict that China will become the second largest pharmaceutical market in the world by 2020.
Comprehensive Analysis of Food Packaging Green Strategy